MECILLINAM: ANOTHER USEFUL DRUG FOR URINARY TRACT INFECTIONS Newsletter Article 15 February 2013 Pages: 2 - 2
PUBLICISING ADVERSE DRUG REACTIONS — A Complaint from the Industry Newsletter Article 15 February 2013 Pages: 2 - 2
WHICH DRUGS FOR ISCHAEMIC PERIPHERAL ARTERIAL DISEASE? Newsletter Article 15 February 2013 Pages: 2 - 2
CYCLOBENZAPRINE IS STILL SOMETHING OF AN UNKNOWN QUANTITY Newsletter Article 15 February 2013 Pages: 3 - 3
MANY CHILDREN NOW SURVIVE LEUKAEMIA — BUT AT WHAT COST? Newsletter Article 15 February 2013 Pages: 3 - 3
DISOPYRAMIDE: PATIENTS SHOULD BE SCREENED FOR HISTORY OF GLAUCOMA Newsletter Article 15 February 2013 Pages: 5 - 5
SENSITIVITY TO LEVAMISOLE TOXICITY IN B27-POSITIVE RA PATIENTS Newsletter Article 15 February 2013 Pages: 6 - 6
BUTORPHANOL — Bristol’s Contribution to the Pool of New Analgesics Newsletter Article 15 February 2013 Pages: 6 - 6
FLUOXETINE IS A SPECIFIC SEROTONIN-REUPTAKE INHIBITOR Newsletter Article 15 February 2013 Pages: 7 - 7
THE CHALLENGE OF DRUG REGULATORY CHANGES Striking a Just and Effective Balance Between Freedom and Authority Newsletter Article 15 February 2013 Pages: 7 - 8
PIVMECILLINAM FOR UT INFECTION — BETTER THAN AMOXYCILLIN Newsletter Article 15 February 2013 Pages: 11 - 11
1,25-VITAMIN D3 HELPS CHILDREN WITH RENAL OSTEODYSTROPHY Newsletter Article 15 February 2013 Pages: 11 - 11
SUCCESSFUL LATE TREATMENT OF PARACETAMOL POISONING WITH MERCAPTAMINE Newsletter Article 15 February 2013 Pages: 12 - 12
AMPICILLIN-RESISTANT HAEMOPHILUS INFLUENZAE ARE INCREASING Newsletter Article 15 February 2013 Pages: 13 - 14
DO SUSTAINED-RELEASE PREPARATIONS OFFER ANY REAL ADVANTAGES? Newsletter Article 15 February 2013 Pages: 14 - 15
HORMONAL THERAPY OF BREAST CANCER: WHAT IS THE PRESENT STATE OF PLAY? Newsletter Article 15 February 2013 Pages: 16 - 17
INDAPAMIDE: AN UNUSUALLY INTERESTING ANTIHYPERTENSIVE Newsletter Article 15 February 2013 Pages: 17 - 18
SCLERODERMA (Progressive Systemic Sclerosis) AND ITS TREATMENT Newsletter Article 15 February 2013 Pages: 19 - 19